Tuesday, February 3, 2026

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Amid Rising Drug Resistance, Korea Begins DOMINO Trial to Reassess First-Line Treatment for Pediatric Mycoplasma

The DOMINO trial will assess treatments for pediatric Mycoplasma pneumonia, addressing rising macrolide resistance in Korea.

Micron’s Latest Forecast Shakes Up Future of U.S. Stock

One of the largest DRAM companies in...

Tag: F-15EX

No posts to display

Top News

- Our Sponsors Ad -

Follow us